Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

New concepts for anticoagulant therapy in persons with hemophilia

Roger E. G. Schutgens, Jeroen F. van der Heijden, Eveline P. Mauser-Bunschoten, Pier M. Mannucci

Blood (2016) 128 (20): 2471–2474.

https://doi.org/10.1182/blood-2016-07-727032

Published: 2016

Journal Articles

von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease

Yvonne V. Sanders, Dafna Groeneveld, Karina Meijer, Karin Fijnvandraat, Marjon H. Cnossen, Johanna G. van der Bom, M. Coppens, Joke de Meris, Britta A. P. Laros-van Gorkom, Eveline P. Mauser-Bunschoten, Frank W. G. Leebeek, Jeroen Eikenboom, the WiN study group

Blood (2015) 125 (19): 3006–3013.

https://doi.org/10.1182/blood-2014-09-603241

Published: 2015

Includes: Supplemental data

Journal Articles

Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial

Peter W. Collins, Guy Young, Karin Knobe, Faraizah Abdul Karim, Pantep Angchaisuksiri, Claus Banner, Türkiz Gürsel, Johnny Mahlangu, Tadashi Matsushita, Eveline P. Mauser-Bunschoten, Johannes Oldenburg, Christopher E. Walsh, Claude Negrier

Blood (2014) 124 (26): 3880–3886.

https://doi.org/10.1182/blood-2014-05-573055

Published: 2014

Includes: Supplemental data

Journal Articles

Willebrand in the Netherlands: WiN Study. Background and Study Design

Eva M. De Wee, MD, Eveline P. Mauser-Bunschoten, MD, PhD, Anske G. Van der Bom, PhD, Jeroen C.J. Eikenboom, MD, PhD, Karin J. Fijn van Draat, MD, PhD, Arja De Goede-Bolder, MD, Karina Meijer, MD, PhD, Irena Nováková, MD, PhD, Iris Plug, PhD, Frank W.G. Leebeek, MD, PhD

Blood (2008) 112 (11): 4510.

https://doi.org/10.1182/blood.V112.11.4510.4510

Published: 2008

Journal Articles

Social participation of patients with hemophilia in the Netherlands

Iris Plug, Marjolein Peters, Eveline P. Mauser-Bunschoten, Arja de Goede-Bolder, Lily Heijnen, Cees Smit, José Willemse, Frits R. Rosendaal, Johanna G. van der Bom

Blood (2008) 111 (4): 1811–1815.

https://doi.org/10.1182/blood-2007-07-102202

Published: 2008

Journal Articles

Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study

Dirk Posthouwer, Michael Makris, Thynn T. Yee, Kathelijn Fischer, Joost J. van Veen, Anja Griffioen, Karel J. van Erpecum, Eveline P. Mauser-Bunschoten

Blood (2007) 109 (9): 3667–3671.

https://doi.org/10.1182/blood-2006-08-038349

Published: 2007

Journal Articles

Bleeding in carriers of hemophilia

Iris Plug, Eveline P. Mauser-Bunschoten, Annette H. J. T. Bröcker-Vriends, Hans Kristian Ploos van Amstel, Johanna G. van der Bom, Joanna E. M. van Diemen-Homan, José Willemse, Frits R. Rosendaal

Blood (2006) 108 (1): 52–56.

https://doi.org/10.1182/blood-2005-09-3879

Published: 2006

Journal Articles

Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization

Eveline P. Mauser-Bunschoten, Jacco A. C. Zijl, Willem Mali, A. Cees van Rinsum, H. Marijke van den Berg, Goris Roosendaal

Blood (2005) 105 (7): 2654–2657.

https://doi.org/10.1182/blood-2004-06-2063

Published: 2005

Journal Articles

Factor VIII Half-Life and Clinical Characteristics of Severe Hemophilia A.

Karin van Dijk, MD, Johanna G. van der Bom, MD, PhD, Eveline P. Mauser-Bunschoten, MD, PhD, Goris Roosendaal, MD, PhD, Peter J. Lenting, PhD, Philip G. de Groot, PhD, H. Marijke van den Berg, MD, PhD

Blood (2004) 104 (11): 3091.

https://doi.org/10.1182/blood.V104.11.3091.3091

Published: 2004

Journal Articles

Variability in Bleeding Pattern of Severe Hemophilia.

Karin van Dijk, MD, Kathelijn Fischer, MD, PhD, Johanna G. van der Bom, MD, PhD, Eveline P. Mauser-Bunschoten, MD, PhD, Goris Roosendaal, MD, PhD, H. Marijke van den Berg, MD, PhD

Blood (2004) 104 (11): 3094.

https://doi.org/10.1182/blood.V104.11.3094.3094

Published: 2004

Journal Articles

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia

Kathelijn Fischer, Johanna G. van der Bom, Eveline P. Mauser-Bunschoten, Goris Roosendaal, Robert Prejs, Piet de Kleijn, Diederick E. Grobbee, Marijke van den Berg

Blood (2002) 99 (7): 2337–2341.

https://doi.org/10.1182/blood.V99.7.2337

Published: 2002

Journal Articles

Hepatitis G Virus RNA and Hepatitis G Virus-E2 Antibodies in Dutch Hemophilia Patients in Relation to Transfusion History

Eveline P. Mauser-Bunschoten, Marjolein Damen, Hans L. Zaaijer, Margret Sjerps, Goris Roosendaal, P. Nico Lelie, H. Theo M. Cuypers, H. Marijke van den Berg

Blood (1998) 92 (6): 2164–2168.

https://doi.org/10.1182/blood.V92.6.2164

Published: 1998

NARROW

New concepts for anticoagulant therapy in persons with hemophilia

von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease

Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial

Willebrand in the Netherlands: WiN Study. Background and Study Design

Social participation of patients with hemophilia in the Netherlands

Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study

Bleeding in carriers of hemophilia

Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization

Factor VIII Half-Life and Clinical Characteristics of Severe Hemophilia A.

Variability in Bleeding Pattern of Severe Hemophilia.

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia

Hepatitis G Virus RNA and Hepatitis G Virus-E2 Antibodies in Dutch Hemophilia Patients in Relation to Transfusion History

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only